Baader Bank Aktiengesellschaft’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
4,768
-18,596
-80% -$4.63M 0.08% 171
2025
Q4
$5.63M Buy
23,364
+12,947
+124% +$3.31M 0.39% 57
2025
Q3
$2.82M Sell
10,417
-19,394
-65% -$5.3M 0.18% 96
2025
Q2
$7.69M Sell
29,811
-211
-0.7% -$50.3K 0.55% 46
2025
Q1
$6.72M Sell
30,022
-4,220
-12% -$985K 0.5% 52
2024
Q4
$7.83M Sell
34,242
-3,325
-9% -$801K 0.51% 55
2024
Q3
$9.14M Sell
37,567
-950
-2% -$212K 0.53% 56
2024
Q2
$7.36M Buy
38,517
+2,958
+8% +$600K 0.47% 69
2024
Q1
$7.04M Buy
35,559
+8,240
+30% +$1.51M 0.5% 53
2023
Q4
$4.7M Buy
27,319
+25,379
+1,308% +$3.9M 0.34% 66
2023
Q3
$283K Buy
+1,940
New +$351K 0.02% 254

Other funds holding RMD

Baader Bank Aktiengesellschaft's RMD Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its ResMed (RMD) stake by 80% in Q1 2026, selling an estimated $4.63M and leaving 4,768 shares worth $1.04M. The position accounts for 0.08% of the portfolio, ranked #171.

Baader Bank Aktiengesellschaft first reported a position in RMD in Q3 2023 and has held it in 11 quarters since. The position peaked at $9.14M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 4,768 shares of ResMed worth $1.04M as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 18,596 ResMed shares in Q1 2026, an estimated $4.63M.
  • ResMed made up 0.08% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #171 holding.
  • Baader Bank Aktiengesellschaft first reported a position in ResMed in Q3 2023 and has held it in 11 quarters since.
  • Baader Bank Aktiengesellschaft's ResMed position peaked at $9.14M in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.